Biological tissue adhesive composition and method of preparation thereof
US-2017216485-A1 · Aug 3, 2017 · US
US2018361015A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2018361015-A1 |
| Application number | US-201615780229-A |
| Country | US |
| Kind code | A1 |
| Filing date | Nov 29, 2016 |
| Priority date | Nov 30, 2015 |
| Publication date | Dec 20, 2018 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
In some embodiments, the present invention provides compositions including silk fibroin, at least one hydrophilic agent, and at least one catechol donating agent, wherein the at least one hydrophilic agent and at least one catechol donating agent are conjugated to the silk fibroin. According to various embodiments, at least a portion of the silk fibroin may be crosslinked. In some embodiments, the silk fibroin is at least 50% (e.g., 60%, 70%, 80%, 90%, 95% or more) crosslinked. In some embodiments, the present invention also provides methods for making such compositions.
Opening claim text (preview).
We claim: 1 . A composition comprising silk fibroin; at least one hydrophilic agent; and at least one catechol donating agent, wherein the at least one hydrophilic agent and at least one catechol donating agent are conjugated to the silk fibroin. 2 . The composition of claim 1 , wherein the at least one hydrophilic agent is selected from the group consisting of poly(ethylene glycol), poly(glutamic acid), poly(lysine), sugars, and oligomers of sugars. 3 . The composition of claim 1 or claim 2 , wherein the at least one catechol donating agent is selected from the group consisting of dopamine, norepinephrine, epinephrine, and L-3,4-dihydroxyphenylalanine. 4 . The composition of any one of the above claims, wherein the at least one hydrophilic agent is present in the composition in an amount at or below 10 substitutions per silk fibroin molecule. 5 . The composition of claim 3 , wherein the at least one hydrophilic agent is poly(ethylene glycol) and is present in the composition in an amount at or below 10 poly(ethylene glycol) chains per silk fibroin molecule. 6 . The composition of claim 5 , wherein the at least one hydrophilic agent is poly(ethylene glycol) and is present in the composition in an amount at or below 5 poly(ethylene glycol) chains per silk fibroin molecule. 7 . The composition of any one of the above claims, wherein the silk fibroin is at least 50% crosslinked. 8 . The composition of claim 7 , wherein the crosslinking of the silk fibroin includes at least one of sonication, vortexing, exposure to low pH environment, methanol treatment, exposure to water vapor, exposure to shear stress, exposure to salt, exposure to elevated pressure, and exposure to an electric field. 9 . The composition of any one of the above claims, wherein the composition is characterized in that, upon exposure to an aqueous environment, the composition does not swell more than 50%, relative to its original size. 10 . The composition of claim 9 , wherein the composition does not swell more than 20%, relative to its original size. 11 . The composition of any one of the above claims, wherein the composition is characterized as having an adhesive force of at least about 20 kPa. 12 . The composition of any one of the above claims, wherein the silk fibroin is functionalized through carboxylation of at least a portion of the serine groups in the silk fibroin. 13 . The composition of any one of the above claims, wherein the dopamine is conjugated to the silk fibroin. 14 . The composition of claim 13 , wherein the conjugation is covalent bonding. 15 . A method comprising providing a silk fibroin solution; associating the silk fibroin solution with at least one hydrophilic agent to form a solubilized silk fibroin solution; and conjugating the solubilized silk fibroin solution with at least one catechol donating agent to form an adhesive silk fibroin composition. 16 . The method of claim 15 , wherein the at least one hydrophilic agent is selected from the group consisting of poly(ethylene glycol), poly(glutamic acid), poly(lysine), sugars, and oligomers of sugars. 17 . The method of claim 15 or claim 16 , wherein the at least one catechol donating agent is selected from the group consisting of dopamine, norepinephrine, epinephrine, and L-3,4-dihydroxyphenylalanine. 18 . The method of claim 15 , wherein the associating step results in not more than 10 substitutions being associated per silk fibroin molecule. 19 . The method of claim 18 , wherein the associating step results in not more than 5 chains being associated per silk fibroin molecule. 20 . The method of claim 17 , wherein the at least one hydrophilic agent is poly(ethylene glycol) and is present in the composition in an amount at or below 10 poly(ethylene glycol) chains per silk fibroin molecule. 21 . The method of claim 20 , wherein the at least one hydrophilic agent is poly(ethylene glycol) and is present in the composition in an amount at or below 5 poly(ethylene glycol) chains per silk fibroin molecule. 22 . The method of any one of claims 15 - 21 , wherein the silk fibroin in the silk fibroin solution is functionalized through carboxylation of at least a portion of the serine groups in the silk fibroin prior to the associating step. 23 . The method of any one of claims 15 - 22 , wherein the adhesive silk fibroin composition is characterized as having an adhesive force of at least about 20 kPa. 24 . The method of any one of 15 - 23 , wherein the adhesive silk fibroin composition does not swell more than 50%, relative to its original size, upon exposure to an aqueous environment. 25 . The method of any one of claims 15 - 24 , wherein the silk fibroin solution is lyophilized prior to the associating step. 26 . The method of any one of claims 15 - 25 , wherein the silk fibroin solution is lyophilized prior to the conjugating step. 27 . The method of any one of claims 15 - 26 , further comprising crosslinking at least a portion of the silk fibroin in the adhesive silk fibroin composition. 28 . The method of claim 27 , wherein the crosslinking occurs after the associating step. 29 . The method of claim 27 , wherein the crosslinking occurs after the conjugating step. 30 . The method of any one of claims 27 - 29 , wherein the crosslinking of the silk fibroin includes at least one of sonication, vortexing, exposure to low pH environment, methanol treatment, exposure to water vapor, exposure to shear stress, exposure to salt, exposure to elevated pressure, and exposure to an electric field.
Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106 · CPC title
obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds (A61L24/043 takes precedence) · CPC title
Materials resorbable by the body · CPC title
Ingredients of undetermined constitution or reaction products thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.